| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $255.2M | — | +11.5% |
| Cost of Revenue | $136.5M | — | +18.2% |
| Gross Profit | $118.7M | — | +4.7% |
| R&D Expense | $6.8M | — | +12.9% |
| SG&A Expense | $62.6M | — | -3.9% |
| Operating Income | $42.5M | — | +26.8% |
| Pre-tax Income | $30.1M | — | +61.2% |
| Income Tax | $6.8M | — | +55.4% |
| Net Income | $23.4M | — | +63.0% |
| EPS (Basic) | $0.11 | — | +57.1% |
| EPS (Diluted) | $0.11 | — | +83.3% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $135.8M | -58.8% | -25.1% |
| Short-term Investments | $94.9M | +36.7% | — |
| Accounts Receivable | $430.9M | +53.8% | +46.7% |
| Inventory | $229.0M | +8.7% | -1.8% |
| Current Assets | $948.3M | -0.3% | +22.6% |
| Total Assets | $3.14B | -0.5% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$150.6M | — | -2475.0% |
| Capital Expenditures | $7.1M | — | +29.3% |
| Investing Cash Flow | -$32.2M | — | -426.3% |
| Financing Cash Flow | -$11.0M | — | -193.6% |
| Free Cash Flow | -$157.8M | — | -1288.0% |
| +5.1% |
| Current Liabilities | $290.8M | -10.0% | -1.2% |
| Long-term Debt | $942.8M | -1.8% | -0.8% |
| Total Liabilities | $1.52B | -2.2% | -1.4% |
| Stockholders' Equity | $1.61B | +1.2% | +12.0% |